Cosmos Health COSM
NASDAQ COSM
$0.25 0.00 (-0.71%)
At close: Sep 10, 2026 · 4:00 PM EDT

Cosmos Health (COSM) Operating Leases (2019 - 2026)

Cosmos Health's (COSM) quarterly Operating Leases came in at $432422.0 in Q2 2026, down 4.64% on a YoY basis from $453442.0 in Q2 2025, and down 6.68% quarter-over-quarter from $463388.0 in Q1 2026.

Analysis

Cosmos Health (COSM) Operating Leases (2019 - 2026) Analysis & Trends

Cosmos Health (COSM) has reported Operating Leases for 8 consecutive years, with $432422.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Leases fell 4.64% year-over-year to $432422.0; the trailing twelve-month figure through Jun 2026 stood at $432422.0 (down 4.64% YoY), and the FY2025 full-year result was $373473.0, down 25.07% from the prior year.
  • Operating Leases fell to $432422.0 in Q2 2026 per COSM's latest filing, from $463388.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $919711.0 in Q1 2023 and bottomed at $373473.0 in Q4 2025.
  • Historically, Operating Leases has averaged $579234.9 across 5 years, with a median of $503642.5 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Operating Leases surged 49.02% in 2023, then sank 44.67% in 2024.
  • Over 5 years, Operating Leases stood at $828762.0 in 2022, then advanced by 1.94% to $844866.0 in 2023, then slumped by 41.01% to $498398.0 in 2024, then slipped by 25.07% to $373473.0 in 2025, then advanced by 15.78% to $432422.0 in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $432422.0, $463388.0, and $373473.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.33 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.05 Bn 18.16 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.76 Bn 9.58 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.38 Bn 5.25 Bn 334.51 Mn
5 Bausch Health Companies 2.27 Bn 436.38 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.51 Bn 1.15 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.03 Bn 737.26 Mn 93.47 Mn
9 Fennec Pharmaceuticals 393.12 Mn 351.87 Mn 17.15 Mn
10 Cosmos Health 15.08 Mn 12.63 Mn 1.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 432,422.00
Mar 31, 2026 463,388.00
Dec 31, 2025 373,473.00
Sep 30, 2025 427,813.00
Jun 30, 2025 453,442.00
Mar 31, 2025 466,909.00
Dec 31, 2024 498,398.00
Sep 30, 2024 468,157.00
Jun 30, 2024 471,697.00
Mar 31, 2024 508,887.00
Dec 31, 2023 844,866.00
Sep 30, 2023 628,179.00
Jun 30, 2023 695,005.00
Mar 31, 2023 919,711.00
Dec 31, 2022 828,762.00
Sep 30, 2022 604,746.00
Jun 30, 2022 723,190.00
Mar 31, 2022 617,183.00
Dec 31, 2021 696,015.00
Sep 30, 2021 739,832.00